ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR
Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
Exploring the Future of Oncology
Join Bionow, industry experts, and colleagues for the highly anticipated 2025 Oncology Conference. This event will delve into the latest advancements and challenges in cancer research, fostering collaboration and innovation across the healthcare sector.
Why Attend?
Innovating Healthcare Through Personalisation
Discover how precision medicine is transforming the healthcare landscape at the 2025 Bionow Precision Medicine Conference. This event brings together thought leaders, innovators, and healthcare professionals to explore advancements in personalised treatment approaches and their impact on patients.
Why Attend?
Hear from inspirational women in the sector!
This event aims to bring together like-minded individuals working in the biotech and life science sector, and women looking to pursue a career in this industry. We will have talks from inspirational women in the industry on topics ranging from leadership, pioneering innovation, achieving success and and the visibility of women in biotech to investment challenges and opportunities and ways to connect with each other.
The event aims to:
By Priya Kalia, SciTribe and Miranda Weston-Smith, BioBeat
London, June 5th 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Melt&Marble and is pleased to announce the placement of Tue Hodal as its first Chief Technology Officer (CTO).
ROLE OVERVIEW
A leading company in the gene therapy sector is seeking a Principal Scientist – Bioassay Development for a 12-month contract based in London, UK. This role offers the chance to work with a pioneering organisation focused on advancing gene therapies for chronic renal diseases.
As the Principal Scientist – Bioassay Development, you will play a critical role in the development and application of in vitro potency assays for gene therapy products, particularly those involving AAV.
We are currently hiring for an innovative biotechnology company at the forefront of scientific discovery and technological integration is seeking a dynamic Vice President of R&D Services in the South East of the UK. Specialising in vector-borne disease control, odour-based biomarker detection, and smart environmental sensing, the organisation is redefining how applied research powers real-world solutions in public health and pest management. The company combines deep scientific expertise with cutting-edge data platforms to drive commercial product development globally.
Read June eNews here
Featuring: